miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.3390/jpm11010031 http://hdl.handle.net/11449/209128 |
Resumo: | Detecting circulating microRNAs (miRNAs; miRs) by means of liquid biopsy is an important tool for the early diagnosis and prognosis of breast cancer (BC). We aimed to identify and validate miR-210 and miR-152 as non-invasive circulating biomarkers, for the diagnosis and staging of BC patients, confirming their involvement in tumor angiogenesis. Methods: RT-qPCR was performed and MiRNA expression analysis was obtained from plasma and fragments of BC and benign breast condition (BBC) women patients, plus healthy subjects. Additionally, the immunohistochemistry technique was carried out to analyze the expression of target proteins. Results: Tumor fragments showed increased expression of oncomiR-210 and decreased expression of miR-152 tumoral suppressor. Both miRNAs were increased in plasma samples from BC patients. The receiver operating characteristic (ROC) curve analysis revealed that only the expression of oncomiR-210 in tissue samples and only the expression of the miR-152 suppressor in plasma have the appropriate sensitivity and specificity for use as differential biomarkers between early/intermediate and advanced stages of BC patients. In addition, there was an increase in the expression of hypoxia-inducible factor 1-alpha (HIF-1 alpha), insulin-like growth factor 1 receptor (IGF-1R), and vascular endothelial growth factor (VEGF) in BC patients. On the contrary, a decrease in Von Hippel-Lindau (VHL) protein expression was observed. Conclusions: This study showed that increased levels of miR-210 and decreased levels of miR152, in addition to the expressions of their target proteins, could indicate, respectively, the oncogenic and tumor suppressive role of these miRNAs in fragments. Both miRNAs are potential diagnostic biomarkers for BC by liquid biopsy. In addition, miR-152 proved to be a promising biomarker for disease staging. |
id |
UNSP_e9c26fe1ab48e1ea9ea210059acbcd98 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/209128 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinomabreast cancermiRNAsliquid biopsyangiogenesisbiomarkersearly diagnosisDetecting circulating microRNAs (miRNAs; miRs) by means of liquid biopsy is an important tool for the early diagnosis and prognosis of breast cancer (BC). We aimed to identify and validate miR-210 and miR-152 as non-invasive circulating biomarkers, for the diagnosis and staging of BC patients, confirming their involvement in tumor angiogenesis. Methods: RT-qPCR was performed and MiRNA expression analysis was obtained from plasma and fragments of BC and benign breast condition (BBC) women patients, plus healthy subjects. Additionally, the immunohistochemistry technique was carried out to analyze the expression of target proteins. Results: Tumor fragments showed increased expression of oncomiR-210 and decreased expression of miR-152 tumoral suppressor. Both miRNAs were increased in plasma samples from BC patients. The receiver operating characteristic (ROC) curve analysis revealed that only the expression of oncomiR-210 in tissue samples and only the expression of the miR-152 suppressor in plasma have the appropriate sensitivity and specificity for use as differential biomarkers between early/intermediate and advanced stages of BC patients. In addition, there was an increase in the expression of hypoxia-inducible factor 1-alpha (HIF-1 alpha), insulin-like growth factor 1 receptor (IGF-1R), and vascular endothelial growth factor (VEGF) in BC patients. On the contrary, a decrease in Von Hippel-Lindau (VHL) protein expression was observed. Conclusions: This study showed that increased levels of miR-210 and decreased levels of miR152, in addition to the expressions of their target proteins, could indicate, respectively, the oncogenic and tumor suppressive role of these miRNAs in fragments. Both miRNAs are potential diagnostic biomarkers for BC by liquid biopsy. In addition, miR-152 proved to be a promising biomarker for disease staging.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto (FAPERP)Inst Biosci Letters & Exact Sci IBILCE, BR-15054000 Sao Jose Do Rio Preto, SP, BrazilFac Med Sao Jose do Rio Preto FAMERP, BR-15054000 Sao Jose Do Rio Preto, SP, BrazilHosp Base Sao Jose do Rio Preto, BR-15090000 Sao Jose Do Rio Preto, SP, BrazilLab Mol Invest Canc LIMC, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, BrazilInst Biosci Letters & Exact Sci IBILCE, BR-15054000 Sao Jose Do Rio Preto, SP, BrazilFAPESP: 2017/11807-3FAPESP: 2017/15006-5Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto (FAPERP): 028/2018MdpiUniversidade Estadual Paulista (Unesp)Fac Med Sao Jose do Rio Preto FAMERPHosp Base Sao Jose do Rio PretoLab Mol Invest Canc LIMCLopes, Beatriz C. [UNESP]Braga, Cristine Z.Ventura, Fabricio V.Oliveira, Jessica G. deKato-Junior, Edson M.Bordin-Junior, Newton A.Zuccari, Debora A. P. C. [UNESP]2021-06-25T11:49:22Z2021-06-25T11:49:22Z2021-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article17http://dx.doi.org/10.3390/jpm11010031Journal Of Personalized Medicine. Basel: Mdpi, v. 11, n. 1, 17 p., 2021.http://hdl.handle.net/11449/20912810.3390/jpm11010031WOS:000610348300001Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal Of Personalized Medicineinfo:eu-repo/semantics/openAccess2021-10-23T19:23:33Zoai:repositorio.unesp.br:11449/209128Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T15:31:58.180317Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma |
title |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma |
spellingShingle |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma Lopes, Beatriz C. [UNESP] breast cancer miRNAs liquid biopsy angiogenesis biomarkers early diagnosis |
title_short |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma |
title_full |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma |
title_fullStr |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma |
title_full_unstemmed |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma |
title_sort |
miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma |
author |
Lopes, Beatriz C. [UNESP] |
author_facet |
Lopes, Beatriz C. [UNESP] Braga, Cristine Z. Ventura, Fabricio V. Oliveira, Jessica G. de Kato-Junior, Edson M. Bordin-Junior, Newton A. Zuccari, Debora A. P. C. [UNESP] |
author_role |
author |
author2 |
Braga, Cristine Z. Ventura, Fabricio V. Oliveira, Jessica G. de Kato-Junior, Edson M. Bordin-Junior, Newton A. Zuccari, Debora A. P. C. [UNESP] |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Fac Med Sao Jose do Rio Preto FAMERP Hosp Base Sao Jose do Rio Preto Lab Mol Invest Canc LIMC |
dc.contributor.author.fl_str_mv |
Lopes, Beatriz C. [UNESP] Braga, Cristine Z. Ventura, Fabricio V. Oliveira, Jessica G. de Kato-Junior, Edson M. Bordin-Junior, Newton A. Zuccari, Debora A. P. C. [UNESP] |
dc.subject.por.fl_str_mv |
breast cancer miRNAs liquid biopsy angiogenesis biomarkers early diagnosis |
topic |
breast cancer miRNAs liquid biopsy angiogenesis biomarkers early diagnosis |
description |
Detecting circulating microRNAs (miRNAs; miRs) by means of liquid biopsy is an important tool for the early diagnosis and prognosis of breast cancer (BC). We aimed to identify and validate miR-210 and miR-152 as non-invasive circulating biomarkers, for the diagnosis and staging of BC patients, confirming their involvement in tumor angiogenesis. Methods: RT-qPCR was performed and MiRNA expression analysis was obtained from plasma and fragments of BC and benign breast condition (BBC) women patients, plus healthy subjects. Additionally, the immunohistochemistry technique was carried out to analyze the expression of target proteins. Results: Tumor fragments showed increased expression of oncomiR-210 and decreased expression of miR-152 tumoral suppressor. Both miRNAs were increased in plasma samples from BC patients. The receiver operating characteristic (ROC) curve analysis revealed that only the expression of oncomiR-210 in tissue samples and only the expression of the miR-152 suppressor in plasma have the appropriate sensitivity and specificity for use as differential biomarkers between early/intermediate and advanced stages of BC patients. In addition, there was an increase in the expression of hypoxia-inducible factor 1-alpha (HIF-1 alpha), insulin-like growth factor 1 receptor (IGF-1R), and vascular endothelial growth factor (VEGF) in BC patients. On the contrary, a decrease in Von Hippel-Lindau (VHL) protein expression was observed. Conclusions: This study showed that increased levels of miR-210 and decreased levels of miR152, in addition to the expressions of their target proteins, could indicate, respectively, the oncogenic and tumor suppressive role of these miRNAs in fragments. Both miRNAs are potential diagnostic biomarkers for BC by liquid biopsy. In addition, miR-152 proved to be a promising biomarker for disease staging. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06-25T11:49:22Z 2021-06-25T11:49:22Z 2021-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3390/jpm11010031 Journal Of Personalized Medicine. Basel: Mdpi, v. 11, n. 1, 17 p., 2021. http://hdl.handle.net/11449/209128 10.3390/jpm11010031 WOS:000610348300001 |
url |
http://dx.doi.org/10.3390/jpm11010031 http://hdl.handle.net/11449/209128 |
identifier_str_mv |
Journal Of Personalized Medicine. Basel: Mdpi, v. 11, n. 1, 17 p., 2021. 10.3390/jpm11010031 WOS:000610348300001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Journal Of Personalized Medicine |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
17 |
dc.publisher.none.fl_str_mv |
Mdpi |
publisher.none.fl_str_mv |
Mdpi |
dc.source.none.fl_str_mv |
Web of Science reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128528612327424 |